五矿资本：10月24日召开董事会会议

Group 1 - The core point of the article is that Wukuang Capital (SH 600390) held its 27th meeting of the 9th board of directors on October 24, 2025, to discuss the reappointment of the auditing institution for the 2025 financial report and internal control [1] - For the first half of 2025, Wukuang Capital's revenue composition is as follows: leasing companies accounted for 37.21%, futures companies 28.15%, trust companies 17.16%, securities companies 15.13%, and other industries 2.33% [1] - As of the report date, Wukuang Capital has a market capitalization of 26.9 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year, highlighting the hot secondary market in biomedicine while questioning the cold fundraising environment in the primary market [1]